Scientists Have Discovered A New Method Of Detecting Cancer.
A altered investigation marketed as an alternative to a mammogram for breast cancer detection is not an moving screening TOOL, US health officials say. With the nipple aspirate test, a heart pump collects fluid from a woman's nipple. The fluid is then examined for peculiar and potentially cancerous cells sex feeling tablets name in sri lanka. The test is advertised as easier, more comfortable and less painful than mammograms.
However, there is no authentication to support claims that the test can detect breast cancer, said Dr David Lerner, a medical policeman at the US Food and Drug Administration and a breast imaging specialist sehat bnane ke tips. "FDA's involve is that the nipple aspirate test is being touted as a standalone tool to screen for and identify breast cancer as an alternative to mammography," Lerner said in an agency news release.
So "Our timidity is that women will forgo a mammogram and have this test instead". Skipping a mammogram could put a woman's healthiness and life at risk if breast cancer goes undetected, Lerner warned. He said there is no systematic evidence that the nipple aspirate test, when used on its own, is an effective screening tool for chest cancer or any other medical condition.
The test is still being studied to determine if it might be useful in combination with other methods to television for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of titty cancer. Mammography is still the gold standard".
In October, 2013, Atossa Genetics pulled its nipple aspirate exam - called the ForeCYTE Breast Health Test - off the merchandise after being warned by the FDA that its claims about the test were unsubstantiated. The company claimed the examine was "literally a Pap smear for breast cancer". Pap smears are a standard probe for cervical cancer.
And Women who have had a nipple aspirate test as a form of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should give to their doctor about whether additional tests are needed, the FDA said. One in eight US women will grow breast cancer in her lifetime malayalam. The blight is the second leading cancer killer of women in the country.
No comments:
Post a Comment